NCT03608579View on ClinicalTrials.gov

Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions

Osteoarthritis, Hip

Interventions

DRUG

Autologous Adipose Derived Mesenchymal Stromal Cells

Human, autologous, culture expanded, adipose derived, mesenchymal stromal cells (AMSCs) produced on site in the Mayo Clinic Human Cellular Therapy Laboratory using current good manufacturing practices

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester